eli lily tirzepatide Lilly, Novo Fight Weight Loss Drug Compounders Over Shortage Lilly releases Zepbound® (tirzepatide) single-dose

In the overall safety population (n = 355), the most frequently reported treatment-related adverse events were dysgeusia (41%), fatigue (28%), dizziness (26%), constipation (23%), and diarrhea (22%)

often under-consumed

At 10mg per week, 4 weeks

Patients may be able to use the service when prescriptions are issued by licensed clinicians and dispensed by appropriately licensed pharmacies, but legality depends on whether the specific compounded product meets federal and state compounding requirements

Wang et al., 2019)

This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Bpc-157 as an active pharmaceutical ingredient (API)